ZA895175B - Piperidine derivatives - Google Patents

Piperidine derivatives

Info

Publication number
ZA895175B
ZA895175B ZA895175A ZA895175A ZA895175B ZA 895175 B ZA895175 B ZA 895175B ZA 895175 A ZA895175 A ZA 895175A ZA 895175 A ZA895175 A ZA 895175A ZA 895175 B ZA895175 B ZA 895175B
Authority
ZA
South Africa
Prior art keywords
chem
formula
group
piperidine derivatives
substituents
Prior art date
Application number
ZA895175A
Other languages
English (en)
Inventor
David Alker
Alker David
Peter Edward Cross
Edward Cross Peter
Robert Michael Wallis
Michael Wallis Robert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA895175B publication Critical patent/ZA895175B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA895175A 1988-07-08 1989-07-07 Piperidine derivatives ZA895175B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816365A GB8816365D0 (en) 1988-07-08 1988-07-08 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA895175B true ZA895175B (en) 1991-02-27

Family

ID=10640168

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895175A ZA895175B (en) 1988-07-08 1989-07-07 Piperidine derivatives

Country Status (28)

Country Link
US (1) US5089505A (zh)
EP (1) EP0350309B1 (zh)
JP (2) JPH0739388B2 (zh)
KR (1) KR930002728B1 (zh)
CN (1) CN1022914C (zh)
AT (1) ATE82262T1 (zh)
AU (1) AU602453B2 (zh)
CA (1) CA1336833C (zh)
DD (1) DD284011A5 (zh)
DE (1) DE68903437T2 (zh)
DK (1) DK337589A (zh)
EG (1) EG18853A (zh)
ES (1) ES2052917T3 (zh)
FI (1) FI94241C (zh)
GB (1) GB8816365D0 (zh)
GR (1) GR3006595T3 (zh)
HU (1) HUT50771A (zh)
IE (1) IE63438B1 (zh)
IL (1) IL90792A0 (zh)
MX (1) MX16728A (zh)
MY (1) MY106976A (zh)
NO (1) NO892828L (zh)
NZ (1) NZ229865A (zh)
PL (2) PL161887B1 (zh)
PT (1) PT91081B (zh)
RU (2) RU1838307C (zh)
YU (1) YU135389A (zh)
ZA (1) ZA895175B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
GB9000301D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Piperidine & pyrrolidine derivatives
GB9208230D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Treatment of delayed gastric emptying
US5340826A (en) * 1993-02-04 1994-08-23 Pfizer Inc. Pharmaceutical agents for treatment of urinary incontinence
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness
US6492400B1 (en) 1998-12-18 2002-12-10 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6525069B1 (en) 1998-12-18 2003-02-25 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6331541B1 (en) 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
EP1161240B1 (en) * 1998-12-18 2005-08-17 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2482100A (en) * 1998-12-18 2000-07-03 Du Pont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6897234B2 (en) 1999-12-17 2005-05-24 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
IL153123A0 (en) 2000-06-30 2003-06-24 Bristol Myers Squibb Co N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
CA2422055A1 (en) * 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US6508872B2 (en) * 2001-02-26 2003-01-21 Hewlett-Packard Company Lightfast additive molecule for inkjet ink
US20090005309A1 (en) * 2007-05-18 2009-01-01 Auspex Pharmaceuticals, Inc. Substituted piperidines
EP2578569B1 (en) * 2010-05-27 2015-10-28 ASKA Pharmaceutical Co., Ltd. Heterocyclic ring compound and h1 receptor antagonist
CN107129453B (zh) * 2016-02-26 2019-10-11 中国科学院大连化学物理研究所 化合物、毒蕈碱m受体拮抗剂、组合物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA541598A (en) * 1957-05-28 Levy Joseph N-substituted-4-benzhydryl etherpiperidines and method for obtaining the same
GB688345A (en) * 1951-02-19 1953-03-04 Greenwood And Hughes Ltd Improvements in sanitary liquid traps
US2745837A (en) * 1954-01-21 1956-05-15 Schering Corp Benzhydryl ethers of alkyl piperidinols
GB780027A (en) * 1955-01-20 1957-07-31 Schering Corp 3-piperidyl ethers and thioethers
US2974146A (en) * 1956-02-24 1961-03-07 Lakeside Lab Inc 3-piperidyl benzhydryl ethers
NL237664A (zh) * 1959-04-01

Also Published As

Publication number Publication date
NZ229865A (en) 1991-01-29
KR900001683A (ko) 1990-02-27
JPH0739388B2 (ja) 1995-05-01
MY106976A (en) 1995-08-30
CA1336833C (en) 1995-08-29
FI94241B (fi) 1995-04-28
DK337589D0 (da) 1989-07-07
EG18853A (en) 1994-12-30
HUT50771A (en) 1990-03-28
DE68903437D1 (de) 1992-12-17
JPH0276851A (ja) 1990-03-16
KR930002728B1 (ko) 1993-04-09
FI94241C (fi) 1995-08-10
PL161887B1 (pl) 1993-08-31
DK337589A (da) 1990-01-09
FI893326A (fi) 1990-01-09
RU1836364C (ru) 1993-08-23
FI893326A0 (fi) 1989-07-07
GB8816365D0 (en) 1988-08-10
MX16728A (es) 1993-08-01
IE892202L (en) 1990-01-08
RU1838307C (ru) 1993-08-30
NO892828D0 (no) 1989-07-07
DE68903437T2 (de) 1993-03-25
IL90792A0 (en) 1990-01-18
DD284011A5 (de) 1990-10-31
PT91081A (pt) 1990-02-08
IE63438B1 (en) 1995-04-19
YU135389A (en) 1991-06-30
EP0350309B1 (en) 1992-11-11
ATE82262T1 (de) 1992-11-15
US5089505A (en) 1992-02-18
JPH07157469A (ja) 1995-06-20
CN1039415A (zh) 1990-02-07
AU602453B2 (en) 1990-10-11
GR3006595T3 (zh) 1993-06-30
NO892828L (no) 1990-01-09
PL162318B1 (pl) 1993-09-30
ES2052917T3 (es) 1994-07-16
CN1022914C (zh) 1993-12-01
AU3797189A (en) 1990-02-15
EP0350309A1 (en) 1990-01-10
PT91081B (pt) 1995-01-31

Similar Documents

Publication Publication Date Title
IL90792A0 (en) Piperidine derivatives
AU613805B2 (en) Pyrimidinedione derivative compounds, method of producing the same and antiarrythmic agents containing the same
AU7578894A (en) Methods for inhibiting smooth muscle cell proliferation and restinosis
ATE198888T1 (de) Antifungizide trisubstituierte tetrahydrofurane
HK1011967A1 (en) Amide derivatives having anti-hyper cholesteremic activity their preparation and their therapeutic uses
HU9402960D0 (en) Methods of inhibiting uterine fibrosis
IL112042A0 (en) Methods of inhibiting seborrhea and acne
AU637150B2 (en) 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
AU7578694A (en) Methods for treating resistant neoplasms
IE890177L (en) Piperidinyl derivatives
EP0176049A3 (en) Aminoalkylnaphtalene derivatives having pharmacological activities